Drug details

Revcovi (elapegademase-lvlr)

type of Enzymes, Metabolic

Revcovi (elapegademase-lvlr) is a recombinant adenosine deaminase indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• vomiting,
• diarrhea,
• fever,
• swollen glands,
• confusion,
• chills,
• seizure,
• weakness,
• unusual tiredness,
• sore throat,
• painful or difficult urination,
• dark colored urine,
• pale or yellowed skin,
• cough with mucus,
• red or pink urine,
• stomach cramps,
• sinus pain,
• breathing problems,
• black or tarry stools,
• bleeding where the medicine was injected,
• other unusual bleeding (nosebleeds, bleeding gums),
• skin warmth or swelling,
• sores or white patches in your mouth or on your skin,
• problems with balance or walking, and
• problems with your teeth or gums

The following drugs are related to Revcovi, either as a replacement or used together:

• Adagen (pegademase bovine)
• Spikevax (covid-19 vaccine, mrna suspension for injection)